SITE011-0075

SITE011 (ITA) › SITE011-0075

SITE011-0075

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE011 (ITA) · Dr. Jansen
consented 2025-11-18

completed

AEs

7

Serious

0

Dropout signal

–

Adverse events

7

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-12-21 (study day 203); relationship: not assessed

mild assessed

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-07 (study day 189); relationship: not assessed

mild assessed

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-24 (study day 115); relationship: NOT RELATED

moderate assessed

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-08-26 (study day 86); relationship: NOT RELATED

mild assessed

Grade 3 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2022-08-23 (study day 83); relationship: not assessed

severe assessed

Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-07-17 (study day 46); relationship: NOT RELATED

mild assessed

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-06-19 (study day 18); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.